Speaker Details

Brian S Kim, MD, FAAD

Brian S Kim, MD, FAAD

SESSIONS

S002 Chronic Pruritus: Bedside to Bench Perspectives
Mar 7, 2025 • 9:00 AM - 12:00 AM • W311G
S031 Dermatology Review: General
Mar 8, 2025 • 1:00 PM - 12:00 AM • W209C
F083 Chronic Urticaria: What's New
Mar 10, 2025 • 9:00 AM - 12:00 AM • W207A

DISCLOSURES

AbbVie – Consultant(Fees); Almirall – Advisory Board(Honoraria); Alys Pharmaceuticals – Stockholder Private Company(Stock); AstraZeneca – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Advisory Board(Honoraria); Evommune, Inc. – Consultant (1099 relationship)(Fees); Galderma – Consultant (1099 relationship)(Fees); Guidepoint Global, LLC – Consultant(Fees); Leo Pharma Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Locus Biosciences – Stockholder(Stock); Novartis – Advisory Board(Honoraria); Pfizer Inc. – Consultant(Honoraria); Recens Medical – Consultant(Fees); Regeneron – Consultant (1099 relationship)(Honoraria); Sanofi – Consultant(Fees); Septerna – Consultant (1099 relationship)(Fees);